[1]
|
J. A. Towbin, “Hypertrophic Cardiomyopathy,” Pacing and Clinical Electrophysiology, Vol. 32, No. S2, 2009, pp. S23-S31. doi:10.1111/j.1540-8159.2009.02381.x
|
[2]
|
S. Gundler, A. Tidholm and J. Haggstrom, “Prevalence of Myocardial Hypertrophy in a Population of Asymptomatic Swedish Maine Coon Cats,” Acta Veterinaria Scandinavica, Vol. 50, 2008, p. 22.
doi:10.1186/1751-0147-50-22
|
[3]
|
M. T. N. Godiksen, S. Granstrom, J. Koch and M. Christiansen, “Hypertrophic Cardiomyopathy in Young Maine Coon Cats Caused by the p.A31P cMyBP-C Mutation— The Clinical Significance of Having the Mutation,” Acta Veterinaria Scandinavica, Vol. 53, No. 7, 2011, pp. 2-11.
|
[4]
|
P. R. Fox, S. K. Liu and B. J. Maron, “Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy. An Animal Model of Human Disease,” Circulation, Vol. 92, No. 9, 1995, pp. 2645-2651. doi:10.1161/01.CIR.92.9.2645
|
[5]
|
M. D. Kittleson, K. M. Meurs, M. J. Munro, J. A. Kittleson, S. K. Liu, P. D. Pion and J. A. Towbin, “Familial Hypertrophic Cardiomyopathy in Maine Coon Cats: An Animal Model of Human Disease,” Circulation, Vol. 99, No. 31, 1999, pp. 72-80.
|
[6]
|
K. M. Meurs, X. Sanchez, R. M. David, N. E. Bowles, J. A. Towbin, P. J. Reiser, J. A. Kittleson, M. J. Munro, K. Dryburgh, K. A. MacDonald and M. D. Kittleson, “A Cardiac Myosin Binding Protein C Mutation in the Maine Coon Cat with Familial Hypertrophic Cardiomyopathy,” Human Molecular Genetics, Vol. 14, No. 23, 2005, pp. 3587-3593. doi:10.1093/hmg/ddi386
|
[7]
|
R. Fries, A. M. Heaney and K. M. Meurs, “Prevalence of the Myosin-Binding Protein C Mutation in Maine Coon Cats,” Journal of Veterinary Internal Medicine, Vol. 22, No. 4, 2008, pp. 893-896.
doi:10.1111/j.1939-1676.2008.0113.x
|
[8]
|
G. Wess, C. Schinner, K. Weber, H. Kuchenhoff and K. Hartmann, “Association of A31P and A74T Polymorphisms in the Myosin Binding Protein C3 Gene and Hypertrophic Cardiomyopathy in Maine Coon and Other Breed Cats,” Journal of Veterinary Internal Medicine, Vol. 24, No. 3, 2010, pp. 527-532.
doi:10.1111/j.1939-1676.2010.0514.x
|
[9]
|
P. S. Andersen, O. Havndrup, H. Bundgaard, L. A. Larsen, J. Vuust, K. A. Pedersen, K. Kjeldsen and M. Christiansen, “Genetic and Phenotypic Characterization of Mutations in Myosin-Binding Protein C (MYBPC3) in 81 Families with Familial Hypertrophic Cardiomyopathy: Total or Partial Haploinsufficiency,” European Journal of Human Genetics, Vol. 12, No. 8, 2004, pp. 673-677.
doi:10.1038/sj.ejhg.5201190
|
[10]
|
A. J. Marian, “Genetic Determinants of Cardiac Hypertrophy,” Current Opinion in Cardiology, Vol. 23, No. 3, 2008, pp. 199-205. doi:10.1097/HCO.0b013e3282fc27d9
|
[11]
|
P. Jaaskelainen, J. Kuusisto, R. Miettinen, P. Karkkainen, S. Karkkainen, S. Heikkinen, P. Peltola, J. Pihlajamaki, I. Vauhkonen and M. Laakso, “Mutations in the Cardiac Myosin-Binding Protein C Gene Are the Predominant Cause of Familial Hypertrophic Cardiomyopathy in Eastern Finland,” Journal of Molecular Medicine, Vol. 80, No. 7, 2002, pp. 412-422. doi:10.1007/s00109-002-0323-9
|
[12]
|
M. Alders, R. Jongbloed, W. Deelen, A. van den Wijngaard, P. Doevendans, F. Ten Cate, V. Regitz-Zagrosek, H. P. Vosberg, I. van Langen, A. Wilde, D. Dooijes and M. Mannens, “The 2373insG Mutation in the MYBPC3 Gene Is a Founder Mutation, Which Accounts for Nearly One-Fourth of the HCM Cases in the Netherlands,” European Heart Journal, Vol. 24, No. 20, 2003, pp. 1848-1853. doi:10.1016/S0195-668X(03)00466-4
|
[13]
|
A. J. Saltzman, D. Mancini-Dinardo, C. Li., W. K. Chung, C. Y. Ho, S. Hurst, J. Wynn, M. Care, R. M. Hamilton, G. W. Seidman, J. Gorham, B. McDonough, E. Sparks, J. G. Seidman, C. E. Seidman and R. L. Rehm, “The Cardiac Myosin Binding Protein C Arg502Trp Mutation. A Common Cause of Hypertrophic Cardiomyopathy,” Circulation Research, Vol. 108, 2010, pp. 743-750.
|
[14]
|
L. Nanni, M. Pieroni, C. Chimenti, B. Simionati, R. Zimbello, A. Maseri, A. Frustaci and G. Lanfranchi, “Hypertrophic Cardiomyopathy: Two Homozygous Cases with ‘Typical’ Hypertrophic Cardiomyopathy and Three New Mutations in Cases with Progression to Dilated Cardiomyopathy,” Biochemical and Biophysical Research Communications, Vol. 309, No. 2, 2003, pp. 391-398.
doi:10.1016/j.bbrc.2003.08.014
|
[15]
|
B. Xin, E. Puffenberger, J. Tumbush, J. R. Bockoven and H. Wang, “Homozygosity for a Novel Splice Site Mutation in the Cardiac Myosin-Binding Protein C Gene Causes Severe Neonatal Hypertrophic Cardiomyopathy,” American Journal of Medical Genetics Part A, Vol. 143A, No. 22, 2007, pp. 2662-2667. doi:10.1002/ajmg.a.31981
|
[16]
|
K. Zahka, K. Kalidas, M. A. Simpson, H. Cross, B. B. Keller, C. Galambos, K. Gurtz, M. A. Patton and A. H. Crosby, “Homozygous Mutation of MYBPC3 Associated with Severe Infantile Hypertrophic Cardiomyopathy at High Frequency among the Amish,” Heart, Vol. 94, No. 10, 2008, pp. 1326-1330. doi:10.1136/hrt.2007.127241
|
[17]
|
C. Moos, C. M. Mason, J. M. Besterman, I. N. Feng and J. H. Dubin, “The Binding of Skeletal Muscle C-Protein to F-Actin, and Its Relation to the Interaction of Actin with Myosin Subfragment-1,” Journal of Molecular Biology, Vol. 124, No. 4, 1978, pp. 571-586.
doi:10.1016/0022-2836(78)90172-9
|
[18]
|
S. P. Harris, C. R. Bartley, T. A. Hacker, K. S. McDonald, P. S. Douglas, M. L. Greaser, P. A. Powers and R. L. Moss, “Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice,” Circulation Research, Vol. 90, No. 5, 2002, pp. 594-601.
doi:10.1161/01.RES.0000012222.70819.64
|
[19]
|
L. Carrier, G. Bonne, E. Bahrend, B. Yu, P. Richard, F. Niel, B. Hainque, C. Cruaud, F. Gary, S. Labeit, J. B. Bouhour, O. Dubourg, M. Desnos, A. A. Hagege, R. J. Trent, M. Komajda, M. Fiszman and K. Schwartz, “Organization and Sequence of Human Cardiac Myosin Binding Protein C Gene (MYBPC3) and Identification of Mutations Predicted to Produce Truncated Proteins in Familial Hypertrophic Cardiomyopathy,” Circulation Research, Vol. 80, No. 3, 1997, pp. 427-434.
|
[20]
|
M. Gautel, O. Zuffardi, A. Freiburg and S. Labeit, “Phosphorylation Switches Specific for the Cardiac Isoform of Myosin Binding Protein-C: A Modulator of Cardiac Contraction?” The EMBO Journal, Vol. 14, No. 9, 1995, pp. 1952-1960.
|
[21]
|
E. Flashman, C. Redwood, J. Moolman-Smook and H. Watkins, “Cardiac Myosin Binding Protein C: Its Role in Physiology and Disease,” Circulation Research, Vol. 94, No. 10, 2004, pp. 1279-1289.
doi:10.1161/01.RES.0000127175.21818.C2
|
[22]
|
H. Niimura, K. K. Patton, W. J. McKenna, J. Soults, B. J. Maron, J. G. Seidman and C. E. Seidman, “Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly,” Circulation, Vol. 105, No. 4, 2002, pp. 446-451. doi:10.1161/hc0402.102990
|
[23]
|
P. Richard, P. Charron, L. Carrier, C. Ledeuil, T. Cheav, C. Pichereau, A. Benaiche, R. Isnard, O. Dubourg, M. Burban, J. P. Gueffet, A. Millaire, M. Desnos, K. Schwartz, B. Hainque and M. Komajda, “Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy,” Circulation, Vol. 107, No. 17, 2003, pp. 2227-2232. doi:10.1161/01.CIR.0000066323.15244.54
|
[24]
|
S. L. Van Driest, V. C. Vasile, S. R. Ommen, M. L. Will, J. A. Tajik, B. J. Gersh and J. M. Ackerman, “Myosin Binding Protein C Mutations and Compound Heterozygosity in Hypertrophic Cardiomyopathy,” Journal of the American College of Cardiology, Vol. 44, No. 9, 2004, pp. 1903-1910. doi:10.1016/j.jacc.2004.07.045
|
[25]
|
J. L. Theis, J. M. Bos, J. D. Theis, D. V. Miller, J. A. Dearani, H. V. Schaff, B. J. Gersh, S. R. Ommen, R. L. Moss and M. J. Ackerman, “Expression Patterns of Cardiac Myofilament Proteins: Genomic and Protein Analysis of Surgical Myectomy Tissue from Patients with Obstructive Hypertrophic Cardiomyopathy,” Circulation: Heart Failure, Vol. 2, No. 4, 2009, pp. 325-333.
doi:10.1161/CIRCHEARTFAILURE.108.789735
|
[26]
|
E. R. Blough, E. R. Rennie, F. Zhang and P. J. Reiser, “Enhanced Electrophoretic Separation and Resolution of Myosin Heavy Chains in Mammalian and Avian Skeletal Muscles,” Analytical Biochemistry, Vol. 233, No. 1, 1996, pp. 31-35. doi:10.1006/abio.1996.0003
|
[27]
|
P. J. Reiser and W. O. Kline, “Electrophoretic Separation and Quantitation of Cardiac Myosin Heavy Chain Isoforms in Eight Mammalian Species,” American Journal of Physiology, Vol. 274, No. 3, 1998, pp. H1048-H1053.
|
[28]
|
A. Shevchenko, M. Wilm, O. Vorm and M. Mann, “Mass Spectrometric Sequencing of Proteins Silver-Stained Polyacrylamide Gels,” Analytical Chemistry, Vol. 68, No. 5, pp. 850-858. doi:10.1021/ac950914h
|
[29]
|
J. Gobom, E. Nordhoff, E. Mirgorodskaya, R. Ekman and P. Roepstorff, “Sample Purification and Preparation Technique Based on Nano-Scale Reversed-Phase Columns for the Sensitive Analysis of Complex Peptide Mixtures by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry,” Journal of Mass Spectrometry, Vol. 34, No. 2, 1999, pp. 105-116.
doi:10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4
|
[30]
|
M. Hass, M. Westerkofsky, S. Muller, B. Becker-Ziaja, C. Busch and S. Gunther, “Mutational Analysis of the Lassa Virus Promoter,” Journal of Virology, Vol. 80, No. 24, 2006, pp. 12414-12419. doi:10.1128/JVI.01374-06
|
[31]
|
E. Flashman, L. Korki, H. Watkins, C. Redwood and J. Moolman-Smook, “Support for a Trimeric Collar of Myosin Binding Protein C in Cardiac and Fast Skeletal Muscle, but Not in Slow Skeletal Muscle,” FEBS Letters, Vol. 582, No. 3, 2008, pp. 434-438.
doi:10.1016/j.febslet.2008.01.004
|
[32]
|
P. Bork, L. Holm and C. Sander, “The Immunoglobulin Fold. Structural Classification, Sequence Patterns and Common Core,” Journal of Molecular Biology, Vol. 242, No. 4, 1994, pp. 309-320.
doi:10.1016/S0022-2836(84)71582-8
|
[33]
|
D. K. Smith and H. Xue, “Sequence Profiles of Immunoglobulin and Immunoglobulin-Like Domains,” Journal of Molecular Biology, Vol. 274, No. 4, 1997, pp. 530-545.
doi:10.1006/jmbi.1997.1432
|
[34]
|
S. C. Li, N. K. Goto, K. A. Williams and C. M. Deber, “Alpha-Helical, but Not Beta-Sheet, Propensity of Proline Is Determined by Peptide Environment,” Proceedings of the National Academy of Sciences of the USA, Vol. 93, No. 13, 1996, pp. 6676-6681.
doi:10.1073/pnas.93.13.6676
|
[35]
|
K. W. Plaxco, C. Spitzfaden, I. D. Campbell and C. M. Dobson, “Rapid Refolding of a Proline-Rich All-Beta-Sheet Fibronectin Type III Module,” Proceedings of the National Academy of Sciences of the USA, Vol. 93, No. 20, 1996, pp. 10703-10706. doi:10.1073/pnas.93.20.10703
|
[36]
|
G. G. Le, F. Y. Dupradeau, C. Mura, S. Jacolot, V. Scotet, G. Esnault, A. Y. Mercier, J. Rochette and C. Ferec, “Phenotypic Expression of the C282Y/Q283P Compound Heterozygosity in HFE and Molecular Modeling of the Q283P Mutation Effect,” Blood Cells Molecules and Diseases, Vol. 30, No. 3, 2003, pp. 231-237.
doi:10.1016/S1079-9796(03)00036-6
|
[37]
|
G. Kunst, K. R. Kress, M. Gruen, D. Uttenweiler, M. Gautel and R. H. Fink, “Myosin Binding Protein C, a Phosphorylation-Dependent Force Regulator in Muscle That Controls the Attachment of Myosin Heads by Its Interaction with Myosin S2,” Circulation Research, Vol. 86, No. 1, 2000, pp. 51-58. doi:10.1161/01.RES.86.1.51
|
[38]
|
I. Kulikovskaya, G. McClellan, J. Flavigny, L. Carrier and S. Winegrad, “Effect of MyBP-C Binding to Actin on Contractility in Heart Muscle,” The Journal of General Physiology, Vol. 122, No. 6, 2003, pp. 761-774.
doi:10.1085/jgp.200308941
|
[39]
|
J. M. Squire, P. K. Luther and C. Knupp, “Structural Evidence for the Interaction of C-Protein (MyBP-C) with Actin and Sequence Identification of a Possible Actin-Binding Domain,” Journal of Molecular Biology, Vol. 331, No. 3, 2003, pp. 713-724.
doi:10.1016/S0022-2836(03)00781-2
|
[40]
|
J. F. Shaffer, R. W. Kensler and S. P. Harris, “The Myosin-Binding Protein C Motif Binds to F-Actin in a Phosphorylation-Sensitive Manner,” The Journal of Biological Chemistry, Vol. 284, No. 18, 2009, pp. 12318-12327. doi:10.1074/jbc.M808850200
|